Back to today’s briefing

Story perspectives

Eli Lilly's Foundayo: FDA Approves New Oral Obesity Treatment

4/1/2026

23 2 Full Breakdown

Summary

Story summary

Eli Lilly's Foundayo received FDA approval on April 1, 2026, becoming the second oral obesity treatment after Wegovy.
Foundayo can be taken anytime without food restrictions.
Pricing starts at $149 per month, with copays as low as $25.
Clinical trials show an average weight loss of 12.4% over 72 weeks.
A public hearing is scheduled for June due to concerns about rapid approval.

1 of 1

Story summary

Eli Lilly's Foundayo received FDA approval on April 1, 2026, becoming the second oral obesity treatment after Wegovy.
Foundayo can be taken anytime without food restrictions.
Pricing starts at $149 per month, with copays as low as $25.
Clinical trials show an average weight loss of 12.4% over 72 weeks.
A public hearing is scheduled for June due to concerns about rapid approval.